< adds gabapentin to Schedule V of the list of controlled substances; and Patients with a substance abuse problem or addiction should be referred to a pain specialist. Theft or loss of controlled substances should be reported to the Drug Enforcement Administration. If drug diversion has occurred, the activity should be documented and reported to law enforcement. H.B. 260 House Floor Audio, Day 18 (2/2/2024) [HB260 Controlled Substances Amendments, Dailey-Provost] Senate Floor Audio, Day 29 (2/13/2024) [HB260 Controlled Substances Amendments, Vickers] Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. Gabapentin will be a Schedule V controlled substance in Utah as of May 1, 2024. Practitioners must have a Utah Controlled Substance License and a DEA registration to prescribe, administer, or dispense Gabapentin. The Controlled Substance Database (CSD) administrator provided a summary of available data on gabapentin dispensing, including 554,879 prescriptions dispensed between Q3 2020, and Q2 2021 (“one year”). Based on data in the CSD, gabapentin is dispensed most commonly to patients in the 55-65 year age group (21%), followed by 65-75 year age group (17.7%), and 45-55 age group (17.2%). The State of Utah Laws and Rules relating to the prescribing of Controlled Substances. Controlled Substances Amendments House Bill (HB) 260 This bill adds gabapentin to the list of controlled substances (CS) as a Schedule V drug. Each pharmacy that dispenses gabapentin will need to ensure that they also have an active Utah Dispensing Controlled Substance License in connection to the Utah pharmacy license. We would like to show you a description here but the site won’t allow us. Utah HB260 2024 General Description This bill adds gabapentin to the list of controlled substances Highlighted Provisions This bill adds gabapentin to Schedule V of New Subsection R156-37f-203 (7) requires the Utah Controlled Substance Database to track the non-controlled substance prescription drug 1 - (Aminomethyl)-cyclohexaneacetic acid (Gabapentin). New Subsection R156-37f-203 (8) clarifies that the Utah Controlled Substance Database tracks derivatives of barbituric acid (Butalbital). The Controlled Substance Database (CSD) administrator provided a summary of available data on gabapentin dispensing, including 339,108 prescriptions dispensed between Q3 2022, and Q2 2023. This data also indicate that gabapentin is dispensed most commonly to patients in the 55-65 year age group (20%), followed by 45-55 year age group (17%), and 35-45 age group (15%). The majority of 22 administering, or dispensing gabapentin, is exempt from the requirements of this chapter. 23 Section 2. Effective Date. 24 This bill takes effect on May 7, 2025. In January 2020, The Drug Regimen Review Center (DRRC) published a report on behalf of Utah Medicaid Drug Utilization Review program, titled, “Abuse and Misuse of Gabapentin.” The report includes information on toxic exposures involving gabapentin. ‘Exposure’ is a common term in clinical toxicology and emergency medicine, wherein a chemical substance comes into contact with the body The Controlled Substances Advisory Committee (CSAC) is pleased to provide for you, as required by law, an update on recommendations for your consideration for action during the 2019 Legislative session. Our committee is composed of individuals with a broad range of expertise and/or experience in public health, clinical care, public safety, and academia. The CSAC has met three times this year The only change in regulation for gabapentin is that it must be to report to the Controlled Substance Database. The Utah State Legislature by statute has given authority to the Utah Controlled Substance Advisory Committee (CSAC) authority to evaluate and track certain substances for which the committee may deem to have a potential for abuse or A controlled substance is a substance with a higher likelihood for addiction and dependence. Here, we’ll talk about the risks associated with gabapentin and why some states consider it a controlled substance. This bill adds gabapentin to the list of controlled substances. Gabapentin is a medication primarily used to treat certain types of nerve pain, but it has also been misused and can have a depressant effect on the central nervous system. By scheduling gabapentin as a controlled substance, this bill aims to help prevent the misuse and potential abuse of the drug. The bill also specifies that it Utah's Controlled Substance Database Program (CSD) is a resource that assists prescribing practitioners and pharmacists in providing efficient care for their patients and customers usage of controlled substances. The Utah Controlled Substance Database Program was legislatively created and put into effect on July 1, 1995. The CSD collects data on the dispensing of Schedule II-V drugs from all UT SB0120 - Controlled Substances ModificationsThis bill creates a specific exemption for veterinarians in Utah's controlled substances regulations regarding gabapentin. Specifically, veterinarians who are licensed under the Veterinary Practice Act will be exempt from the standard controlled substances requirements when prescribing, administering, or dispensing gabapentin within their
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |